
Kimia Biosciences Ltd is Rated Strong Sell
2026-08-09 10:10:17Kimia Biosciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 27 July 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 09 August 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Kimia Biosciences Ltd Forms Death Cross, Signalling Potential Bearish Trend
2026-08-07 18:20:16Kimia Biosciences Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential deterioration in the stock’s trend and raises concerns about sustained bearish momentum in the Pharmaceuticals & Biotechnology sector.
Read full news articleWhen is the next results date for Kimia Biosciences Ltd?
2026-08-04 23:18:10The next results date for Kimia Biosciences Ltd is scheduled for August 10, 2026....
Read full news article
Kimia Biosciences Downgraded to Strong Sell Amid Weak Financials and Bearish Technicals
2026-07-28 08:11:00Kimia Biosciences Ltd has been downgraded from a Sell to a Strong Sell rating as of 27 Jul 2026, reflecting deteriorating fundamentals and a shift to bearish technical indicators. The micro-cap pharmaceutical company’s financial performance has weakened significantly, while valuation and technical trends have also contributed to the negative outlook.
Read full news article
Kimia Biosciences Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals
2026-07-22 08:07:47Kimia Biosciences Ltd has seen its investment rating upgraded from Strong Sell to Sell, reflecting a nuanced shift in its technical outlook amid persistent fundamental challenges. While the company’s financial performance remains under pressure, recent technical indicators have improved, prompting a reassessment of its near-term prospects.
Read full news article
Kimia Biosciences Ltd is Rated Strong Sell
2026-07-21 10:10:04Kimia Biosciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 17 June 2026, reflecting a significant reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 21 July 2026, providing investors with the latest view of the company’s position in the market.
Read full news article
Kimia Biosciences Ltd is Rated Strong Sell
2026-07-10 10:10:30Kimia Biosciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 June 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 10 July 2026, providing investors with the latest insights into its performance and outlook.
Read full news article
Kimia Biosciences Ltd is Rated Strong Sell
2026-06-29 10:10:26Kimia Biosciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 June 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Kimia Biosciences Downgraded to Strong Sell Amid Weak Financials and Technical Setbacks
2026-06-18 08:05:52Kimia Biosciences Ltd has been downgraded from a Sell to a Strong Sell rating following a comprehensive reassessment of its quality, valuation, financial trends, and technical indicators. The downgrade reflects deteriorating fundamentals, persistent financial weakness, and a shift in technical momentum, signalling heightened risks for investors in this micro-cap pharmaceutical company.
Read full news articleBoard Meeting Outcome for Outcome Of Board Meeting Held On August 10 2026 (Monday)
10-Aug-2026 | Source : BSEPursuant to Regulation 33 and 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we have enclosed herewith:
Unaudited Financial Results For The First Quarter Ended June 30 2026
10-Aug-2026 | Source : BSEApproval of unaudited financial result (Standalone) for quarter ended june 30 2026.
Board Meeting Intimation for Regulation 29 Of SEBI (LODR) Regulations 2015 -Intimation Of Meeting Of Board Of Directors.
03-Aug-2026 | Source : BSEKimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 inter alia to consider and approve Un-Audited Financial Results (Standalone) for the first quarter ended on June 30th 2026.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






